Sodium Caseinate from Human Milk: Properties & Research Uses

Sodium caseinate from Human Milk is a water-soluble, sodium salt form of human milk casein that serves as a biochemically relevant protein standard and functional ingredient for nutrition science, neonatal research, and protein interaction studies.

Source

Human milk (Homo sapiens)

Chemical Form

Sodium salt of casein (caseinate)

Solubility

Soluble in water; forms colloidal dispersions at higher concentrations

Primary Protein Components

αs1-, αs2-, β-, and κ-casein subfractions

Biological Relevance

Major nitrogen source for neonatal development; distinct composition from bovine casein

Typical Application

Protein biochemistry, neonatal nutrition models, proteomics, cell culture studies

What Is Sodium Caseinate from Human Milk?

Sodium caseinate is produced by acid precipitation of casein from milk followed by solubilization with sodium hydroxide, yielding a sodium salt that is substantially more water-soluble than native casein. When derived from human milk, this reagent preserves the unique protein subfraction profile of human casein, which differs meaningfully from the more commonly studied bovine caseinate in both relative subfraction ratios and post-translational modification patterns.

Human milk casein comprises a mixture of phosphoproteins—principally β-casein, with smaller proportions of αs1-, αs2-, and κ-casein—assembled into colloidal structures known as casein micelles. These micelles are stabilized by calcium phosphate nanoclusters and hydrophobic interactions. In the sodium caseinate form, the calcium is largely replaced by sodium, disrupting the native micelle architecture and yielding an open, more accessible protein matrix suitable for biochemical assays and in vitro experiments.

Biochemical Properties and Composition

Human milk caseins are highly phosphorylated proteins with an intrinsically disordered structure, meaning they lack a stable globular tertiary conformation under physiological conditions. This structural flexibility allows them to bind and solubilize large quantities of calcium and phosphate, a property critical for neonatal bone mineralization.

The dominant subfraction in human milk casein is β-casein, which differs from bovine milk where αs1-casein predominates. This compositional difference has significant downstream implications for digestibility, bioactive peptide release upon proteolysis, and interaction with neonatal digestive enzymes. The sodium caseinate form retains these phosphoprotein characteristics while offering improved solubility for laboratory handling.

Key physicochemical properties of sodium caseinate include a high surface activity (making it an effective emulsifier), susceptibility to enzymatic hydrolysis by proteases such as trypsin, chymotrypsin, and plasmin, and the capacity to release bioactive peptides with opioid, antimicrobial, or ACE-inhibitory activity upon digestion.

Research Applications

Neonatal Nutrition Modeling: Sodium caseinate from human milk is used as a reference material in studies designed to model neonatal protein digestion, amino acid bioavailability, and the gastrointestinal processing of human milk proteins. Its distinct composition relative to bovine caseinate makes it the preferred standard when physiological fidelity to the human infant is required.

Proteomics and Bioactive Peptide Research: The reagent serves as a substrate for protease digestion experiments aimed at identifying and characterizing casein-derived bioactive peptides. Researchers studying opioid receptor ligands, antihypertensive peptides, or antimicrobial peptides derived from human milk use this substrate to generate authentic human-origin hydrolysates.

Protein Interaction and Structural Studies: The intrinsically disordered nature of casein makes it a useful model protein for studying protein–ligand interactions, chaperone activity, and amyloid aggregation inhibition. Human milk-derived caseinate provides a physiologically relevant variant for such mechanistic investigations.

Cell Culture and In Vitro Bioassays: Sodium caseinate can be used to supplement defined media or as a coating substrate to study cell adhesion, differentiation, and enterocyte responses to milk proteins, particularly in models of intestinal epithelial function relevant to infant gut health.

Handling, Storage, and Quality Considerations

Sodium caseinate from human milk should be stored according to the manufacturer's recommended conditions, typically at 2–8 °C or −20 °C for long-term storage, protected from moisture and repeated freeze-thaw cycles. As a protein derived from human biological material, all applicable biosafety regulations regarding human-sourced reagents should be observed; researchers should consult their institutional biosafety committee guidelines prior to use.

Dissolution is typically achieved by dispersing the powder in aqueous buffer at neutral to slightly alkaline pH (pH 6.5–8.0) with gentle stirring; sonication may be used to facilitate complete solubilization. Solutions should be prepared fresh or stored at 4 °C and used within a short period to minimize microbial contamination and protein degradation.

Quality attributes to verify upon receipt include protein content (typically assessed by Kjeldahl or Dumas nitrogen determination with an appropriate nitrogen-to-protein conversion factor), electrophoretic purity by SDS-PAGE, and absence of endotoxin where cell culture applications are intended. Lot-specific certificates of analysis should be reviewed for compliance with experimental requirements.

Frequently asked questions

How does sodium caseinate from human milk differ from bovine sodium caseinate?

Human milk sodium caseinate differs primarily in its subfraction composition: β-casein is the dominant component in human milk, whereas αs1-casein predominates in bovine milk. This leads to differences in digestibility, bioactive peptide profiles upon hydrolysis, micelle structure, and interaction with infant digestive enzymes, making the human milk-derived form the appropriate reference for research requiring physiological relevance to the human neonate.

Is sodium caseinate from human milk suitable for cell culture applications?

Sodium caseinate from human milk can be used in cell culture applications, but researchers must verify that the specific lot is tested for endotoxin and sterility, or filter-sterilize solutions prior to use. As a human-sourced material, compliance with institutional biosafety requirements is also mandatory. Lot-specific certificates of analysis should be reviewed for relevant quality parameters before use in sensitive biological assays.

What is the recommended method for dissolving sodium caseinate from human milk?

Sodium caseinate from human milk is best dissolved by slowly dispersing the powder into an aqueous buffer or water at neutral to slightly alkaline pH (approximately pH 6.5–8.0) with continuous gentle stirring at room temperature. If complete dissolution is not achieved by stirring alone, mild sonication can be applied. Freshly prepared solutions are recommended; if storage is necessary, keep at 4 °C and use within a short timeframe to prevent microbial growth and protein degradation.

What safety precautions should be taken when working with sodium caseinate from human milk?

As a reagent derived from human biological material, sodium caseinate from human milk should be handled following universal precautions applicable to human-sourced materials. Researchers should consult their institutional biosafety committee for site-specific requirements, use appropriate personal protective equipment, and follow local regulations for handling, disposal, and record-keeping of human-derived biological reagents.

References

1. Holt C, Carver JA, Ecroyd H, Thorn DC. Invited review: Caseins and the casein micelle: Their biological functions, structures, and behavior in foods. Journal of Dairy Science. 2013;96(10):6127-6146. doi:10.3168/jds.2013-6559
2. Lonnerdal B. Nutritional and physiologic significance of human milk proteins. American Journal of Clinical Nutrition. 2003;77(6):1537S-1543S.
3. Picariello G, Ferranti P, Fierro O, et al. Peptides surviving the simulated gastrointestinal digestion of milk proteins: Biological and toxicological implications. Journal of Chromatography B. 2010;878(3-4):295-308.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.